Received Nov 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 1 | — | — |
Pharmacist called and reported an adult patient who missed doses of GARDASIL 9. Patient only received a first dose of GARDASIL 9 on 18OCT2024. No additional AE/no PQC.; No additional AE/no PQC.; This spontaneous report was received from a pharmacist and refers to an adult patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies, previous drugs reactions and allergies were not reported. On 18-Oct-2024, the patient was vaccinated with the first dose of human papillomavirus 9-valent vaccine, recombinant (GARDASIL 9), suspension for injection, 1 dosage form, administered as prophylaxis (strength, Lot No., expiration date, exact dose quantity volume, route and anatomical location of administration and vaccination scheme frequency were not provided). It was stated that the patient only received this previous mention first dose and missed doses of the vaccine (inappropriate schedule of product administration) No additional adverse event was reported (No adverse event).